亨斯邁股票討論區

$亨斯邁(HUN.US)$🎯 2023.8.1 當前價格28.7，持倉浮虧6%，距離上次買入已經13個月
新增數據：2022全年及2023前兩季度
2022年營收增長4.6%，營業利潤增長2%，由於去年其他淨收入達到5.7億，今年這個科目僅有100萬，因此淨利潤大幅下滑52.6%，其實核心盈利能力並沒有變化。
2023前兩季度營收下滑32.6%，營業利潤下滑82%，淨利潤下滑59%。
目前市盈率12.7，市盈率TTM增長到了26.9，對於週期股來說估值缺乏吸引力。

Gapping up
In reaction to earnings/guidance:
• $Bowlero(BOWL.US)$ +3.4%
Other news:
• $Intellia Therapeutics(NTLA.US)$ +10.8% (Interim Clinical Data for its Second Systemically Delivered Investigational CRISPR Candidate, NTLA-2002)
• $Gogo Inc(GOGO.US)$ +5% (Repurchases 1.5 million shares of common stock from BlackRock)
• $ADC Therapeutics(ADCT.US)$ +2.9% (ADC Therapeutics and Swedish Orphan Biovitrum AB (BIOVF) confirms positive CHM...

Gainers:
• $National Vision(EYE.US)$ +13.8% (appointed to join S&P SmallCap 600)
• $Braze(BRZE.US)$ +12.2% (In reaction to earnings/guidance)
• $甲骨文(ORCL.US)$ +11.7% (In reaction to earnings/guidance)
• $TeraWulf(WULF.US)$ +7.5% (announced recent financing actions and near-term ramp of digital infrastructure)
• $大陸能源(CLR.US)$ +7.5% (announces receipt of "take private" proposal from Hamm Family of $70/share)
•...

Upgrades
• $B&G食品(BGS.US)$ : Piper Sandler Upgrades to Neutral from Underweight - PT $23 (from $25)
• $諾基亞(NOK.US)$ : Citigroup Upgrades to Buy from Neutral
• $美國網存(NTAP.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $84 (from $90)
• $PBF Energy(PBF.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $57 (from $30)
• $US Silica(SLCA.US)$ : Evercore ISI Upgrades to Outperform from In Line - PT $20
• $湯森路透(TRI.US)$ : CIBC Up...

$亨斯邁(HUN.US)$
毛利率基本在20%左右，營業利潤主要受營收變化影響，因此營業收入和營業利潤曲線比較吻合。但是淨利潤在近三年都大幅超過營業利潤，主要原因是特殊收入較多。淨資產收益率除2018年，基本在20～33%之間，還是相當不錯的。
2021年扣非稅前淨利爲7.4億，稅後大約6.2億，對應12倍市盈率。考慮到超高增速是基於2019和2020兩年大幅萎縮後的超低基數，增長率要打個大折扣。
利息費用近5年不斷下降，從1.65億下降到了0.67億，負擔目前不高。
近5年在縮表，資產負債率從67%下降到了52%，長期借款從22.6億下降到了15.4億，是45.59億淨資產的34%。
5年來經營淨額45.3億大幅超過投資淨額7.2億，盈餘很多。
目前市盈率7.5，市盈率TTM6.6，值得選擇（⭐️⭐️）

Gainers
• $Plantronics(POLY.US)$ +50% (to be acquired by HP Inc ($惠普(HPQ.US)$) for $40.00 per share)
• $Axsome Therapeutics(AXSM.US)$ +21.6% (Jazz Pharma divests Sunosi to Axsome Therapeutics)
• $STAAR Surgical(STAA.US)$ +15.4% (receives FDA approval of EVO Visian Implantable Collamer Lenses)
• $Sarcos Technology & Robotics(STRC.US)$ +7.6% (announces that the Company has reached a definitive merger agreement to acquire Pittsburgh-base...

Gainers
• $Anaplan(PLAN.US)$ +28.2% (to be acquired by Thoma Bravo for $66.00 per share)
• $Guess(GES.US)$ +5.04% (entered into an accelerated share repurchase agreement to repurchase $175 mln of its common stock)
• $Membership Collective(MCG.US)$ +2.8% (authorizes stock repurchase program to repurchase up to $50 mln of the Company's Class A common stock)
• $Sorrento Therapeutics(SRNE.US)$ +2.3% (reports promising results with a universal...